Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-II infection with initial neurological manifestation.

E Klemm1, K E Schneweis, R Horn

  • 1Neurologische Klinik, Universität Bonn, Federal Republic of Germany.

Journal of Neurology
|May 1, 1988
PubMed
Summary

This case study details a patient with Human Immunodeficiency Virus type II (HIV-II) infection who developed severe neurological symptoms, including spastic paraplegia and cognitive decline, due to chronic central nervous system inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of the Concentration of Different Amino Acids on the Corrosion Behavior of Mg Alloy AZ31-A Respirometric Study.

Journal of biomedical materials research. Part B, Applied biomaterials·2025
Same author

Coupling electrochemical CO<sub>2</sub> reduction to microbial product generation - identification of the gaps and opportunities.

Current opinion in biotechnology·2021
Same author

Results of a randomised controlled trial between an ORC collagen hemostatic agent and a carrier-bound fibrin sealant.

Journal of visceral surgery·2020
Same author

Fungal colonization of the paranasal sinuses.

Mycoses·2017
Same author

The genomic architecture of mastitis resistance in dairy sheep.

BMC genomics·2017
Same author

[Acute poisoning in adults].

Der Internist·2014

Area of Science:

  • Neurology
  • Infectious Diseases
  • Immunology

Background:

  • Human Immunodeficiency Virus type II (HIV-II) is an uncommon cause of neurological disease.
  • Travel history to endemic regions is crucial for diagnosing geographically dispersed infections.

Observation:

  • A patient with positive HIV-II serology presented with progressive neurological decline.
  • Symptoms included asthenia, incontinence, gait disturbance, cognitive impairment, and personality changes.
  • The patient ultimately developed spastic paraplegia and peripheral neuropathy.

Findings:

  • Cerebral atrophy and chronic central nervous system inflammation were identified.
  • The clinical presentation was consistent with an acquired immunodeficiency syndrome-related neurological disorder.

Related Experiment Videos

Implications:

  • This case highlights the importance of considering HIV-II in the differential diagnosis of unexplained neurological conditions, especially in patients with relevant travel history.
  • Further research is needed to understand the pathogenesis and optimize treatment strategies for HIV-II-associated neuroinflammation.